Rachael Kalicun

Rachael Kalicun

CollabRx Chairman Tenenbaum To Host Panel at Leading Personalized Medicine Meeting

CollabRx Chairman Marty Tenenbaum will chair a panel session entitled “Let’s Look at Cancer: What’s Happening in Personalized Medicine” at the 7th Annual Burrill & Company Personalized Medicine Meeting in October. View the Burrill Personalized Medicine Meeting Agenda.

James Karis Joins CollabRx As CEO

Founder Marty Tenenbaum takes role of Chairman. About CollabRx…

CollabRx Scientists Jeff Shrager, Marty Tenenbaum, and Mike Travers Describe Cancer Commons in “Collaborative Computational Technologies for Biomedical Research”

Methods, Processes, and Tools for Collaboration “The time has come to fundamentally rethink how we handle the building of knowledge in biomedical sciences today. This book describes how the computational sciences have transformed into being a key knowledge broker, able to integrate and operate across divergent data types.”—Bryn Williams-Jones, Associate Research Fellow, Pfizer The pharmaceutical […]

CollabRx Team Proposes Curing Cancer As New Grand Challenge for AI

CollabRx CEO Marty Tenenbaum and CTO Jeff Shrager describe Cancer Commons and propose curing cancer as a new Grand Challenge for AI in the latest issue of AI Magazine. Read Abstract or Download Complete PDF.

Unexpected Death of Director and Chief Medical Officer, John G. Curd, MD

A Statement from Marty Tenenbaum The entire team of staff, board members and advisors at CollabRx is saddened by the unexpected passing of our friend and colleague, John G. Curd, MD. As our consulting Chief Medical Officer, Dr. Curd played an invaluable role in making CollabRx what it is today. Dr. Curd’s intelligence and professional […]

ASCO and CollabRx Form Partnership

The American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization that leverages information technology to personalize cancer treatments and accelerate research have forged a strategic partnership to develop innovative, Web-based decision support tools that enable physicians and their patients to better […]

Three CollabRx Scientists/Execs To Speak at Silicom Ventures’ Personalized Medicine World Conference

CollabRx CEO Dr. Marty Tenenbaum, CTO Dr. Jeff Shrager, and CollabRx Editor in Chief Dr. George Lundberg will be speaking at the 2011 Silicom Ventures’ Personalized Medicine World Conference on January 18 and 19, 2011. See Full Speaker List

CollabRx CEO Marty Tenenbaum Interviewed in Xconomy

Marty Tenenbaum, CollabRx CEO, is interviewed in the online business journal Xconomy. Read the Article “Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons”.

CollabRx Scientists Co-Author Peer-Reviewed Publication on Drug Ranking for Melanoma Treatment

CollabRx CTO Dr. Jeff Shrager and Director of Engineering Dr. Randy Gobbel collaborated with eight other researchers in publishing “Targeted Therapy Database (TTD): A Model to Match Patient’s Molecular Profile with Current Knowledge on Cancer Biology”, which appeared in the open source journal PLoS ONE. Read Targeted Therapy Database (TTD): A Model to Match Patient’s […]

Personalized Molecular Medicine: The Turning Point in Fighting Cancer

Amos Barzilay discussed the current state of the fight against cancer as well as potential business opportunities in personalized medicine at the Silicom Summit on personalized medicine on August 11, 2009. View Event Details